Status:
NOT_YET_RECRUITING
To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects
Lead Sponsor:
Dong-A ST Co., Ltd.
Conditions:
Healthy
Eligibility:
All Genders
19+ years
Phase:
PHASE1
Brief Summary
This study is to evaluate the effect of food on pharmacokinetics of DA-5222 in healthy adult subjects
Eligibility Criteria
Inclusion
- Healthy volunteers
- BMI between 18 and 30 kg/m2
- Body weight: Male≥50kg, Female≥45kg
- Subjects who have signed an informed consent themselves after receiving detailed explanation about clinical study
Exclusion
- Subjects with clinically significant medical history
- Subjects with history of drug abuse or addicted
- Subjects with allergy or drug hypersensitivity
Key Trial Info
Start Date :
May 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06993168
Start Date
May 21 2025
End Date
July 1 2025
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bumin Hospital
Seoul, South Korea, South Korea